# PrEP Among MSM and TG in Myanmar

> **NCT04781426** · — · COMPLETED · sponsor: **Myanmar Oxford Clinical Research Unit** · enrollment: 200 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Tenofovir Disoproxil Fumarate (TDF) 300 mg

## Key facts

- **NCT ID:** NCT04781426
- **Lead sponsor:** Myanmar Oxford Clinical Research Unit
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-28
- **Primary completion:** 2021-08-31
- **Final completion:** 2021-08-31
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2022-03-11

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04781426

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04781426, "PrEP Among MSM and TG in Myanmar". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT04781426. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*